https://www.immunocore.com/science/publications/rss en-us https://d1io3yog0oux5.cloudfront.net/_b541aae032f58bf8fdbdeabb137fc49f/immunocore/files/theme/images/logo-sm.png https://www.immunocore.com Equisolve Investor Relations Suite https://www.immunocore.com/news-views-OLD/publicatiions/detail/22205/tebentafusp-a-tcranti-cd3-bispecific-fusion-protein-targeting-gp100-potentially-activated-antitumour-immune-responses-in-patients-with-metastatic-melanoma Tue, 18 Aug 20 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22205/tebentafusp-a-tcranti-cd3-bispecific-fusion-protein-targeting-gp100-potentially-activated-antitumour-immune-responses-in-patients-with-metastatic-melanoma https://www.immunocore.com/news-views-OLD/publicatiions/detail/22206/epub-ahead-of-print-immune-mobilising-monoclonal-t-cell-receptors-mediate-specific-and-rapid-elimination-of-hepatitis-b-infected-cells Mon, 27 Apr 26 21:51:46 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22206/epub-ahead-of-print-immune-mobilising-monoclonal-t-cell-receptors-mediate-specific-and-rapid-elimination-of-hepatitis-b-infected-cells https://www.immunocore.com/news-views-OLD/publicatiions/detail/22207/t-cell-receptors-with-distinct-specificity-profiles-use-different-binding-modes-to-engage-an-identical-peptide-hla-complex-j-immunol-2020-apr-1-2047-1943-1953 Thu, 06 Feb 20 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22207/t-cell-receptors-with-distinct-specificity-profiles-use-different-binding-modes-to-engage-an-identical-peptide-hla-complex-j-immunol-2020-apr-1-2047-1943-1953 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22208/tebentafusp-t-cell-redirection-for-the-treatment-of-advanced-uveal-melanoma-cancers-2019-jul-11-117-pii-e971 Thu, 11 Jul 19 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22208/tebentafusp-t-cell-redirection-for-the-treatment-of-advanced-uveal-melanoma-cancers-2019-jul-11-117-pii-e971 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22209/tcr-induced-alteration-of-primary-mhc-peptide-anchor-residue-eur-j-immunol-2019-jul-497-1052-1066 Wed, 15 May 19 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22209/tcr-induced-alteration-of-primary-mhc-peptide-anchor-residue-eur-j-immunol-2019-jul-497-1052-1066 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22210/novel-tcr-based-biologics-mobilising-t-cells-to-warm-cold-tumours-cancer-treat-rev-2019-jul-77-35-43 Mon, 27 Apr 26 21:51:46 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22210/novel-tcr-based-biologics-mobilising-t-cells-to-warm-cold-tumours-cancer-treat-rev-2019-jul-77-35-43 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22211/assessing-the-potency-of-t-cell-redirecting-therapeutics-using-in-vitro-cancer-cell-killing-assays-immuno-oncology-cellular-and-translational-approaches-springer-methods-2019 Tue, 01 Jan 19 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22211/assessing-the-potency-of-t-cell-redirecting-therapeutics-using-in-vitro-cancer-cell-killing-assays-immuno-oncology-cellular-and-translational-approaches-springer-methods-2019 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22212/intra-patient-escalation-dosing-strategy-with-imcgp100-results-in-mitigation-of-t-cell-based-toxicity-and-preliminary-efficacy-in-advanced-uveal-melanoma-2017-asco Tue, 30 May 17 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22212/intra-patient-escalation-dosing-strategy-with-imcgp100-results-in-mitigation-of-t-cell-based-toxicity-and-preliminary-efficacy-in-advanced-uveal-melanoma-2017-asco https://www.immunocore.com/news-views-OLD/publicatiions/detail/22213/safety-efficacy-and-biology-of-the-gp100-tcr-based-bispecific-t-cell-redirector-imcgp100-in-advanced-uveal-melanoma-in-two-phase-1-trials-2017-sitc Mon, 27 Apr 26 21:51:46 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22213/safety-efficacy-and-biology-of-the-gp100-tcr-based-bispecific-t-cell-redirector-imcgp100-in-advanced-uveal-melanoma-in-two-phase-1-trials-2017-sitc https://www.immunocore.com/news-views-OLD/publicatiions/detail/22214/polyfunctional-response-by-immtac-imcgp100-redirected-cd8-and-cd4-t-cells-2017-immunology-1523-425-438 Mon, 27 Apr 26 21:51:46 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22214/polyfunctional-response-by-immtac-imcgp100-redirected-cd8-and-cd4-t-cells-2017-immunology-1523-425-438 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22215/safety-pharmacokinetics-and-efficacy-of-imcgp100-a-first-in-class-soluble-tcr-anticd3-bispecific-t-cell-redirector-with-solid-tumour-activity-results-from-the-fih-study-in-melanoma-2016-asco Mon, 16 May 16 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22215/safety-pharmacokinetics-and-efficacy-of-imcgp100-a-first-in-class-soluble-tcr-anticd3-bispecific-t-cell-redirector-with-solid-tumour-activity-results-from-the-fih-study-in-melanoma-2016-asco https://www.immunocore.com/news-views-OLD/publicatiions/detail/22216/immtac-redirected-tumour-cell-killing-induces-and-potentiates-antigen-cross-presentation-by-dendritic-cells-2014-cancer-immunol-immunother-635-437-48 Mon, 27 Apr 26 21:51:46 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22216/immtac-redirected-tumour-cell-killing-induces-and-potentiates-antigen-cross-presentation-by-dendritic-cells-2014-cancer-immunol-immunother-635-437-48 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22217/examining-the-presentation-of-tumor-associated-antigens-on-peptide-pulsed-t2-cells-2013-oncoimmunology-nov-1-211-e26840 Mon, 27 Apr 26 21:51:46 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22217/examining-the-presentation-of-tumor-associated-antigens-on-peptide-pulsed-t2-cells-2013-oncoimmunology-nov-1-211-e26840 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22218/immtacs-for-targeted-cancer-therapy-why-what-how-and-which-2015-mol-immunol-672-pt-a-67-74 Mon, 27 Apr 26 21:51:46 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22218/immtacs-for-targeted-cancer-therapy-why-what-how-and-which-2015-mol-immunol-672-pt-a-67-74 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22219/bi-specific-tcr-anti-cd3-redirected-t-cell-targeting-of-ny-eso-1--and-lage-1-positive-tumors-2013-cancer-immunol-immunother-624-773-85 Mon, 27 Apr 26 21:51:46 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22219/bi-specific-tcr-anti-cd3-redirected-t-cell-targeting-of-ny-eso-1--and-lage-1-positive-tumors-2013-cancer-immunol-immunother-624-773-85 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22220/immtacs-novel-bi-specific-agents-for-targeted-cancer-therapy-2013-oncoimmunology-22-1-2 Mon, 27 Apr 26 21:51:46 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22220/immtacs-novel-bi-specific-agents-for-targeted-cancer-therapy-2013-oncoimmunology-22-1-2 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22221/monoclonal-tcr-redirected-tumor-cell-killing-2012-nat-med-186-980-7 Mon, 27 Apr 26 21:51:46 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22221/monoclonal-tcr-redirected-tumor-cell-killing-2012-nat-med-186-980-7 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22222/elimination-of-latently-hiv-infected-cells-from-antiretroviral-therapy-suppressed-subjects-by-engineered-immune-mobilising-t-cell-receptors-2016-molecular-therapy-2411-1913-1925 Mon, 27 Apr 26 21:51:46 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22222/elimination-of-latently-hiv-infected-cells-from-antiretroviral-therapy-suppressed-subjects-by-engineered-immune-mobilising-t-cell-receptors-2016-molecular-therapy-2411-1913-1925 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22223/production-of-a-soluble-disulfide-bond-linked-tcr-in-the-cytoplasm-of-escherichia-coli-trxb-gor-mutants-2010-mol-biotechnol-452-140-9 Mon, 27 Apr 26 21:51:46 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22223/production-of-a-soluble-disulfide-bond-linked-tcr-in-the-cytoplasm-of-escherichia-coli-trxb-gor-mutants-2010-mol-biotechnol-452-140-9 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22224/directed-evolution-of-human-t-cell-receptor-cdr2-residues-by-phage-display-dramatically-enhances-affinity-for-cognate-peptide-mhc-without-increasing-apparent-cross-reactivity-2006-protein-sci-154-710-21 Mon, 27 Apr 26 21:51:46 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22224/directed-evolution-of-human-t-cell-receptor-cdr2-residues-by-phage-display-dramatically-enhances-affinity-for-cognate-peptide-mhc-without-increasing-apparent-cross-reactivity-2006-protein-sci-154-710-21 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22225/directed-evolution-of-human-t-cell-receptors-with-picomolar-affinities-by-phage-display-2005-nat-biotechnol-233-349-54 Mon, 27 Apr 26 21:51:46 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22225/directed-evolution-of-human-t-cell-receptors-with-picomolar-affinities-by-phage-display-2005-nat-biotechnol-233-349-54 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22226/making-high-affinity-t-cell-receptors-a-new-class-of-targeted-therapeutics-2006-idrugs-98-554-9 Mon, 27 Apr 26 21:51:46 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22226/making-high-affinity-t-cell-receptors-a-new-class-of-targeted-therapeutics-2006-idrugs-98-554-9 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22227/stable-soluble-high-affinity-engineered-t-cell-receptors-novel-antibody-like-proteins-for-specific-targeting-of-peptide-antigens-2005-clin-exp-immunol-1423-454-60 Thu, 01 Dec 05 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22227/stable-soluble-high-affinity-engineered-t-cell-receptors-novel-antibody-like-proteins-for-specific-targeting-of-peptide-antigens-2005-clin-exp-immunol-1423-454-60 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22228/stable-soluble-t-cell-receptor-molecules-for-crystallization-and-therapeutics-2003-protein-eng-169-707-11 Mon, 01 Sep 03 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22228/stable-soluble-t-cell-receptor-molecules-for-crystallization-and-therapeutics-2003-protein-eng-169-707-11 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22229/crystal-structures-of-high-affinity-human-t-cell-receptors-bound-to-peptide-major-histocompatibility-complex-reveal-native-diagonal-binding-geometry-2007-protein-eng-des-sel-208-397-403 Mon, 27 Apr 26 21:51:46 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22229/crystal-structures-of-high-affinity-human-t-cell-receptors-bound-to-peptide-major-histocompatibility-complex-reveal-native-diagonal-binding-geometry-2007-protein-eng-des-sel-208-397-403 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22230/direct-molecular-mimicry-enables-off-target-cardiovascular-toxicity-by-an-enhanced-affinity-tcr-designed-for-cancer-immunotherapy-2016-sci-rep-6-18851 Mon, 27 Apr 26 21:51:46 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22230/direct-molecular-mimicry-enables-off-target-cardiovascular-toxicity-by-an-enhanced-affinity-tcr-designed-for-cancer-immunotherapy-2016-sci-rep-6-18851 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22231/identification-of-a-titin-derived-hla-a1-presented-peptide-as-a-cross-reactive-target-for-engineered-mage-a3-directed-t-cells-2013-sci-trans-med-aug-7-5197-197ra103 Mon, 27 Apr 26 21:51:46 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22231/identification-of-a-titin-derived-hla-a1-presented-peptide-as-a-cross-reactive-target-for-engineered-mage-a3-directed-t-cells-2013-sci-trans-med-aug-7-5197-197ra103 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22232/antigen-selection-for-enhanced-affinity-t-cell-receptor-based-cancer-therapies-2016-j-biomol-screen-218-769-85 Mon, 27 Apr 26 21:51:46 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22232/antigen-selection-for-enhanced-affinity-t-cell-receptor-based-cancer-therapies-2016-j-biomol-screen-218-769-85 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22233/quantifying-and-imaging-ny-eso-1lage-1-derived-epitopes-on-tumor-cells-using-high-affinity-t-cell-receptors-2006-j-immunol-17612-7308-16 Mon, 27 Apr 26 21:51:46 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22233/quantifying-and-imaging-ny-eso-1lage-1-derived-epitopes-on-tumor-cells-using-high-affinity-t-cell-receptors-2006-j-immunol-17612-7308-16 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22234/high-affinity-monoclonal-t-cell-receptor-mtcr-fusions-fusion-protein-technologies-for-biopharmaceuticals-applications-and-challenges-2013 Mon, 27 Apr 26 21:51:46 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22234/high-affinity-monoclonal-t-cell-receptor-mtcr-fusions-fusion-protein-technologies-for-biopharmaceuticals-applications-and-challenges-2013 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22235/the-t-cell-promise-2013-european-biopharmaceutical-review-summer-2013 Sun, 01 Dec 13 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22235/the-t-cell-promise-2013-european-biopharmaceutical-review-summer-2013 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22236/different-affinity-windows-for-virus-and-cancer-specific-t-cell-receptors-implications-for-therapeutic-strategies-2012-eur-j-immunol-4212-3174-9 Mon, 27 Apr 26 21:51:46 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22236/different-affinity-windows-for-virus-and-cancer-specific-t-cell-receptors-implications-for-therapeutic-strategies-2012-eur-j-immunol-4212-3174-9 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22237/redirected-t-cell-lysis-in-patients-with-metastatic-uveal-melanoma-with-gp100-direct-tcr-imcgp100-overall-survival-findings-2018-asco Mon, 27 Apr 26 21:51:46 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22237/redirected-t-cell-lysis-in-patients-with-metastatic-uveal-melanoma-with-gp100-direct-tcr-imcgp100-overall-survival-findings-2018-asco https://www.immunocore.com/news-views-OLD/publicatiions/detail/22238/is-cellr-a-user-friendly-tool-for-analyzing-and-visualizing-single-cell-rna-sequencing-data-2018-bioinformatics Mon, 27 Apr 26 21:51:46 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22238/is-cellr-a-user-friendly-tool-for-analyzing-and-visualizing-single-cell-rna-sequencing-data-2018-bioinformatics https://www.immunocore.com/news-views-OLD/publicatiions/detail/22239/an-approved-in-vitro-approach-to-preclinical-safety-and-efficacy-evaluation-of-engineered-t-cell-receptor-anti-cd3-bispecific-immtac-molecules-2018-plos-one Mon, 27 Apr 26 21:51:46 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22239/an-approved-in-vitro-approach-to-preclinical-safety-and-efficacy-evaluation-of-engineered-t-cell-receptor-anti-cd3-bispecific-immtac-molecules-2018-plos-one https://www.immunocore.com/news-views-OLD/publicatiions/detail/22240/reliable-in-silico-ranking-of-engineered-therapeutic-tcr-binding-affinities-with-mmpbgbsa-j-chem-inf-model-2022-623-577-590 Thu, 20 Jan 22 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22240/reliable-in-silico-ranking-of-engineered-therapeutic-tcr-binding-affinities-with-mmpbgbsa-j-chem-inf-model-2022-623-577-590 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22241/microfluidic-mediated-self-assembly-of-phospholipids-for-the-delivery-of-biologic-molecule-int-j-pharm-2022-611-121347 Wed, 05 Jan 22 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22241/microfluidic-mediated-self-assembly-of-phospholipids-for-the-delivery-of-biologic-molecule-int-j-pharm-2022-611-121347 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22242/structure-guided-stabilization-of-pathogen-derived-peptide-hla-e-complexes-using-non-natural-amino-acids-conserves-native-tcr-recognition-eur-j-immunol-2022-524-618-632 Wed, 02 Feb 22 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22242/structure-guided-stabilization-of-pathogen-derived-peptide-hla-e-complexes-using-non-natural-amino-acids-conserves-native-tcr-recognition-eur-j-immunol-2022-524-618-632 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22243/phase-i-study-of-safety-tolerability-and-efficacy-of-tebentafusp-using-a-step-up-dosing-regimen-and-expansion-in-patients-with-metastatic-uveal-melanoma-j-clin-oncol2022-4017-1939 Mon, 07 Mar 22 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22243/phase-i-study-of-safety-tolerability-and-efficacy-of-tebentafusp-using-a-step-up-dosing-regimen-and-expansion-in-patients-with-metastatic-uveal-melanoma-j-clin-oncol2022-4017-1939 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22244/unconventional-modes-of-peptide-hla-i-presentation-change-the-rules-of-tcr-engagement-discov-immunol-2022-11-kyac001 Wed, 04 May 22 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22244/unconventional-modes-of-peptide-hla-i-presentation-change-the-rules-of-tcr-engagement-discov-immunol-2022-11-kyac001 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22245/therapeutic-high-affinity-t-cell-receptor-targeting-a-krassupg12dsup-cancer-neoantigen-nat-comms-2022-131-5333 Sat, 10 Sep 22 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22245/therapeutic-high-affinity-t-cell-receptor-targeting-a-krassupg12dsup-cancer-neoantigen-nat-comms-2022-131-5333 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22246/clinical-and-molecular-response-to-tebentafusp-in-previously-treated-patients-with-metastatic-uveal-melanoma-a-phase-2-trial-nat-med-2022-2811-2364-2373 Thu, 13 Oct 22 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22246/clinical-and-molecular-response-to-tebentafusp-in-previously-treated-patients-with-metastatic-uveal-melanoma-a-phase-2-trial-nat-med-2022-2811-2364-2373 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22247/combination-strategies-to-durably-suppress-hiv-1-soluble-t-cell-receptors-j-virus-erad-2022-83-100082 Sat, 03 Sep 22 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22247/combination-strategies-to-durably-suppress-hiv-1-soluble-t-cell-receptors-j-virus-erad-2022-83-100082 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22248/immune-mobilising-t-cell-receptors-redirect-polyclonal-cd8-t-cells-in-chronic-hiv-infection-to-form-immunological-synapses-sci-rep-2022-121-18366 Tue, 01 Nov 22 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22248/immune-mobilising-t-cell-receptors-redirect-polyclonal-cd8-t-cells-in-chronic-hiv-infection-to-form-immunological-synapses-sci-rep-2022-121-18366 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22249/unconventional-mait-cell-responses-to-bacterial-infections-semin-immunol-2022-61-64-101663 Tue, 01 Nov 22 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22249/unconventional-mait-cell-responses-to-bacterial-infections-semin-immunol-2022-61-64-101663 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22250/the-manufacturing-of-3d-printed-microfluidic-chips-to-analyse-the-effect-upon-particle-size-during-the-synthesis-of-lipid-nanoparticles-jpharmpharmacol-2022-rgac085 Thu, 01 Dec 22 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22250/the-manufacturing-of-3d-printed-microfluidic-chips-to-analyse-the-effect-upon-particle-size-during-the-synthesis-of-lipid-nanoparticles-jpharmpharmacol-2022-rgac085 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22251/redirecting-polyclonal-t-cells-against-cancer-with-soluble-t-cell-receptors-clin-cancer-res-2023-294-697-704 Wed, 15 Feb 23 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22251/redirecting-polyclonal-t-cells-against-cancer-with-soluble-t-cell-receptors-clin-cancer-res-2023-294-697-704 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22252/tebentafusp-in-combination-with-durvalumab-andor-tremelimumab-in-patients-with-metastatic-cutaneous-melanoma-a-phase-1-study-j-immunother-cancer-2023-jun-116-e006747 Wed, 07 Jun 23 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22252/tebentafusp-in-combination-with-durvalumab-andor-tremelimumab-in-patients-with-metastatic-cutaneous-melanoma-a-phase-1-study-j-immunother-cancer-2023-jun-116-e006747 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22253/promiscuous-recognition-of-mr1-drives-self-reactive-mucosal-associated-invariant-t-cell-responses-j-exp-med-4-september-2023-220-9-e20221939 Thu, 29 Jun 23 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22253/promiscuous-recognition-of-mr1-drives-self-reactive-mucosal-associated-invariant-t-cell-responses-j-exp-med-4-september-2023-220-9-e20221939 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22254/high-affinity-cd8-variants-enhance-the-sensitivity-of-pmhci-antigen-recognition-via-low-affinity-tcrs-j-biol-chem-2023-2998-104981 Tue, 01 Aug 23 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22254/high-affinity-cd8-variants-enhance-the-sensitivity-of-pmhci-antigen-recognition-via-low-affinity-tcrs-j-biol-chem-2023-2998-104981 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22255/microfluidic-encapsulation-of-enzymes-and-steroids-within-solid-lipid-nanoparticles-drug-deliv-transl-res-2024-141-266-279 Fri, 28 Jul 23 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22255/microfluidic-encapsulation-of-enzymes-and-steroids-within-solid-lipid-nanoparticles-drug-deliv-transl-res-2024-141-266-279 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22256/tuning-the-potency-and-selectivity-of-immtac-molecules-by-affinity-modulation-clin-exp-immunol-2024-2152-105-119 Wed, 01 Nov 23 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22256/tuning-the-potency-and-selectivity-of-immtac-molecules-by-affinity-modulation-clin-exp-immunol-2024-2152-105-119 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22257/three-year-overall-survival-with-tebentafusp-in-metastatic-uveal-melanoma-n-engl-j-med-2023-38924-2256-2266 Sat, 21 Oct 23 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22257/three-year-overall-survival-with-tebentafusp-in-metastatic-uveal-melanoma-n-engl-j-med-2023-38924-2256-2266 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22258/a-call-to-adapt-the-regulation-of-hla-testing-for-t-cell-receptor-based-therapeutics-nat-rev-drug-discov-2024-231-1-2 Wed, 29 Nov 23 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22258/a-call-to-adapt-the-regulation-of-hla-testing-for-t-cell-receptor-based-therapeutics-nat-rev-drug-discov-2024-231-1-2 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22259/overall-survival-from-tebentafusp-versus-nivolumab-plus-ipilimumab-in-first-line-metastatic-uveal-melanoma-a-propensity-score-weighted-analysis-ann-oncol-2024-353-317-326 Sat, 02 Dec 23 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22259/overall-survival-from-tebentafusp-versus-nivolumab-plus-ipilimumab-in-first-line-metastatic-uveal-melanoma-a-propensity-score-weighted-analysis-ann-oncol-2024-353-317-326 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22260/instability-of-the-hla-e-peptidome-of-hiv-presents-a-major-barrier-to-therapeutic-targeting-mol-ther-2024-323-678-688 Fri, 12 Jan 24 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22260/instability-of-the-hla-e-peptidome-of-hiv-presents-a-major-barrier-to-therapeutic-targeting-mol-ther-2024-323-678-688 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22261/an-hla-e-targeted-tcr-bispecific-molecule-redirects-t-cell-immunity-against-mycobacterium-tuberculosis-proc-natl-acad-sci-u-s-a-2024-12119-e2318003121 Wed, 01 May 24 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22261/an-hla-e-targeted-tcr-bispecific-molecule-redirects-t-cell-immunity-against-mycobacterium-tuberculosis-proc-natl-acad-sci-u-s-a-2024-12119-e2318003121 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22262/long-term-survival-follow-up-for-tebentafusp-in-previously-treated-metastatic-uveal-melanoma-j-immunother-cancer-2024-126-e009028 Thu, 06 Jun 24 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22262/long-term-survival-follow-up-for-tebentafusp-in-previously-treated-metastatic-uveal-melanoma-j-immunother-cancer-2024-126-e009028 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22407/t-cell-receptors-with-distinct-specificity-profiles-use-different-binding-modes-to-engage-an-identical-peptide-hla-complex-j-immunol-2020-2047-1943-1953 Wed, 01 Apr 20 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22407/t-cell-receptors-with-distinct-specificity-profiles-use-different-binding-modes-to-engage-an-identical-peptide-hla-complex-j-immunol-2020-2047-1943-1953 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22408/specificity-of-bispecific-tcrs-and-antibodies-targeting-peptide-hla-j-clin-invest-2020-1305-2673-2688 Mon, 20 Apr 20 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22408/specificity-of-bispecific-tcrs-and-antibodies-targeting-peptide-hla-j-clin-invest-2020-1305-2673-2688 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22409/t-cell-receptor-interactions-with-human-leukocyte-antigen-govern-indirect-peptide-selectivity-for-the-cancer-testis-antigen-mage-a4-j-biol-chem-2020-29533-11486-11494 Sun, 30 Aug 20 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22409/t-cell-receptor-interactions-with-human-leukocyte-antigen-govern-indirect-peptide-selectivity-for-the-cancer-testis-antigen-mage-a4-j-biol-chem-2020-29533-11486-11494 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22410/molecular-rules-underpinning-enhanced-affinity-binding-of-t-cell-receptors-engineered-for-immunotherapy-mol-ther-oncolytics-2020-18-443-456 Fri, 25 Sep 20 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22410/molecular-rules-underpinning-enhanced-affinity-binding-of-t-cell-receptors-engineered-for-immunotherapy-mol-ther-oncolytics-2020-18-443-456 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22411/immune-mobilising-monoclonal-t-cell-receptors-mediate-specific-and-rapid-elimination-of-hepatitis-b-infected-cells-hepatology-2020-nov-725-1528-1540-doi-10-1002hep-31503 Fri, 06 Nov 20 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22411/immune-mobilising-monoclonal-t-cell-receptors-mediate-specific-and-rapid-elimination-of-hepatitis-b-infected-cells-hepatology-2020-nov-725-1528-1540-doi-10-1002hep-31503 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22412/tebentafusp-a-tcranti-cd3-bispecific-fusion-protein-targeting-gp100-potently-activated-anti-tumor-immune-responses-in-patients-with-metastatic-melanoma-clin-can-res-2020-aug-18-doi-10-11581078-0432-ccr-20-1247 Fri, 13 Nov 20 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22412/tebentafusp-a-tcranti-cd3-bispecific-fusion-protein-targeting-gp100-potently-activated-anti-tumor-immune-responses-in-patients-with-metastatic-melanoma-clin-can-res-2020-aug-18-doi-10-11581078-0432-ccr-20-1247 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22413/engineering-soluble-t-cell-receptors-for-therapy-febs-journal-2021-feb-23-doi-10-1111febs-15780 Tue, 23 Feb 21 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22413/engineering-soluble-t-cell-receptors-for-therapy-febs-journal-2021-feb-23-doi-10-1111febs-15780 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22414/clinical-trials-in-metastatic-uveal-melanoma-immunotherapy-ocul-oncol-pathol-2021-7-168-176-doi-10-1159000513336 Wed, 31 Mar 21 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22414/clinical-trials-in-metastatic-uveal-melanoma-immunotherapy-ocul-oncol-pathol-2021-7-168-176-doi-10-1159000513336 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22415/incoming-hiv-virion-derived-gag-spacer-peptide-2-p1-is-a-target-of-effective-cd8-t-cell-antiviral-responses-cell-rep-2021-may-11-356-109103-doi-10-1016j-celrep-2021-109103 Tue, 11 May 21 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22415/incoming-hiv-virion-derived-gag-spacer-peptide-2-p1-is-a-target-of-effective-cd8-t-cell-antiviral-responses-cell-rep-2021-may-11-356-109103-doi-10-1016j-celrep-2021-109103 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22416/the-present-and-future-role-of-microfluidics-for-protein-and-peptide-based-therapeutics-and-diagnostics-appl-sci-2021-119-4109-doi-10-3390app11094109 Fri, 30 Apr 21 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22416/the-present-and-future-role-of-microfluidics-for-protein-and-peptide-based-therapeutics-and-diagnostics-appl-sci-2021-119-4109-doi-10-3390app11094109 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22417/allosteric-activation-of-t-cell-antigen-receptor-signaling-by-quaternary-structure-relaxation-cell-rep-2021-july-13-362-109375-doi-10-1016j-celrep-2021-109375 Tue, 13 Jul 21 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22417/allosteric-activation-of-t-cell-antigen-receptor-signaling-by-quaternary-structure-relaxation-cell-rep-2021-july-13-362-109375-doi-10-1016j-celrep-2021-109375 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22439/enhanced-target-specific-delivery-of-docetaxel-loaded-nanoparticles-using-engineered-t-cell-receptors-nanoscale-1335-15010-15020-doi-10-1039d1nr04001d Fri, 20 Aug 21 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22439/enhanced-target-specific-delivery-of-docetaxel-loaded-nanoparticles-using-engineered-t-cell-receptors-nanoscale-1335-15010-15020-doi-10-1039d1nr04001d https://www.immunocore.com/news-views-OLD/publicatiions/detail/22418/cell-targeted-pd-1-agonists-that-mimic-pd-l1-are-potent-t-cell-inhibitors-jci-insight-2021-sep-7-152468-doi-10-1172jci-insight-152468 Tue, 07 Sep 21 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22418/cell-targeted-pd-1-agonists-that-mimic-pd-l1-are-potent-t-cell-inhibitors-jci-insight-2021-sep-7-152468-doi-10-1172jci-insight-152468 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22419/overall-survival-benefit-with-tebentafusp-in-metastatic-uveal-melanoma-n-engl-j-med-2021-sep-23-38513-1196-1206-doi-10-1056nejmoa2103485 Sun, 22 Aug 21 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22419/overall-survival-benefit-with-tebentafusp-in-metastatic-uveal-melanoma-n-engl-j-med-2021-sep-23-38513-1196-1206-doi-10-1056nejmoa2103485 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22420/microfluidic-mediated-self-assembly-of-phospholipids-for-the-delivery-of-biologic-molecules-int-j-pharm-2021-dec-7-611-121347-doi-10-1016j-ijpharm-2021-121347 Wed, 05 Jan 22 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22420/microfluidic-mediated-self-assembly-of-phospholipids-for-the-delivery-of-biologic-molecules-int-j-pharm-2021-dec-7-611-121347-doi-10-1016j-ijpharm-2021-121347 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22422/tebentafusp-induces-a-t-cell-driven-rash-in-melanocyte-bearing-skin-as-an-adverse-event-consistent-with-the-mechanism-of-action-j-invest-dermatol-published-online-july-15-2024 Mon, 15 Jul 24 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22422/tebentafusp-induces-a-t-cell-driven-rash-in-melanocyte-bearing-skin-as-an-adverse-event-consistent-with-the-mechanism-of-action-j-invest-dermatol-published-online-july-15-2024 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22421/insights-into-the-cd1-lipidome-front-immunol-2024-aug-22-15-1462209-doi-10-3389fimmu-2024-1462209 Thu, 22 Aug 24 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22421/insights-into-the-cd1-lipidome-front-immunol-2024-aug-22-15-1462209-doi-10-3389fimmu-2024-1462209 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22624/dual-role-of-the-peptide-loading-complex-as-proofreader-and-limiter-of-mhc-i-presentation-proc-natl-acad-sci-usa-121-22-e2321600121 Tue, 21 May 24 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22624/dual-role-of-the-peptide-loading-complex-as-proofreader-and-limiter-of-mhc-i-presentation-proc-natl-acad-sci-usa-121-22-e2321600121 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22626/broadening-specificity-of-t-cell-receptors-for-hla-a03-01a11-01-alloselectivity-scientific-reports Wed, 06 Nov 24 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22626/broadening-specificity-of-t-cell-receptors-for-hla-a03-01a11-01-alloselectivity-scientific-reports https://www.immunocore.com/news-views-OLD/publicatiions/detail/22628/gingisrex-a-complementary-enzyme-for-the-detection-of-bacterial-proteins-journal-of-the-american-society-for-mass-spectrometry Wed, 04 Dec 24 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22628/gingisrex-a-complementary-enzyme-for-the-detection-of-bacterial-proteins-journal-of-the-american-society-for-mass-spectrometry https://www.immunocore.com/news-views-OLD/publicatiions/detail/22630/viral-sequence-determines-hla-e-restricted-t-cell-recognition-of-hepatitis-b-surface-antigen-nat-comms Fri, 22 Nov 24 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22630/viral-sequence-determines-hla-e-restricted-t-cell-recognition-of-hepatitis-b-surface-antigen-nat-comms https://www.immunocore.com/news-views-OLD/publicatiions/detail/22632/high-affinity-t-cell-receptor-immtac-bispecific-efficiently-redirects-t-cells-to-1-kill-tumor-cells-expressing-the-cancer-testis-antigen-prame-immunotherapy-advances Sat, 02 Nov 24 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22632/high-affinity-t-cell-receptor-immtac-bispecific-efficiently-redirects-t-cells-to-1-kill-tumor-cells-expressing-the-cancer-testis-antigen-prame-immunotherapy-advances https://www.immunocore.com/news-views-OLD/publicatiions/detail/22634/characterization-of-human-cd8-interaction-with-classical-and-unconventional-mhc-molecules-eur-j-immunol Fri, 20 Dec 24 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22634/characterization-of-human-cd8-interaction-with-classical-and-unconventional-mhc-molecules-eur-j-immunol https://www.immunocore.com/news-views-OLD/publicatiions/detail/22709/high-affinity-t-cell-receptor-immtac-bispecific-efficiently-redirects-t-cells-to-1-kill-tumor-cells-expressing-the-cancer-testis-antigen-prame-immunotherapy-advances Fri, 01 Nov 24 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22709/high-affinity-t-cell-receptor-immtac-bispecific-efficiently-redirects-t-cells-to-1-kill-tumor-cells-expressing-the-cancer-testis-antigen-prame-immunotherapy-advances https://www.immunocore.com/news-views-OLD/publicatiions/detail/22711/characterization-of-human-cd8-interaction-with-classical-and-unconventional-mhc-molecules-eur-j-immunol Sun, 01 Dec 24 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22711/characterization-of-human-cd8-interaction-with-classical-and-unconventional-mhc-molecules-eur-j-immunol https://www.immunocore.com/news-views-OLD/publicatiions/detail/22713/tebentafusp-a-t-cell-engager-promotes-macrophage-reprogramming-and-in-combination-with-il-2-overcomes-macrophage-immunosuppression-in-cancer Sat, 01 Mar 25 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22713/tebentafusp-a-t-cell-engager-promotes-macrophage-reprogramming-and-in-combination-with-il-2-overcomes-macrophage-immunosuppression-in-cancer https://www.immunocore.com/news-views-OLD/publicatiions/detail/22715/synthetic-t-cell-receptor-like-protein-behaves-as-a-janus-particle-in-solution Wed, 01 Jan 25 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22715/synthetic-t-cell-receptor-like-protein-behaves-as-a-janus-particle-in-solution https://www.immunocore.com/news-views-OLD/publicatiions/detail/22717/phase-1-study-of-imcnyeso-a-t-cell-receptor-bispecific-immtac-targeting-ny-eso-1-expressing-malignancies Sat, 01 Feb 25 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22717/phase-1-study-of-imcnyeso-a-t-cell-receptor-bispecific-immtac-targeting-ny-eso-1-expressing-malignancies https://www.immunocore.com/news-views-OLD/publicatiions/detail/22719/t-cell-receptor-structures-and-predictive-models-reveal-comparable-alpha-and-beta-chain-structural-diversity-despite-differing-genetic-complexity Sat, 01 Mar 25 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22719/t-cell-receptor-structures-and-predictive-models-reveal-comparable-alpha-and-beta-chain-structural-diversity-despite-differing-genetic-complexity https://www.immunocore.com/news-views-OLD/publicatiions/detail/22721/molecular-basis-underpinning-mr1-allomorph-recognition-by-an-mr1-restricted-t-cell-receptor Sat, 01 Mar 25 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22721/molecular-basis-underpinning-mr1-allomorph-recognition-by-an-mr1-restricted-t-cell-receptor https://www.immunocore.com/news-views-OLD/publicatiions/detail/22723/radiomic-markers-associated-with-clinical-benefit-in-patients-with-radiographic-progression-of-advanced-uveal-melanoma-on-tebentafusp Sat, 01 Mar 25 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22723/radiomic-markers-associated-with-clinical-benefit-in-patients-with-radiographic-progression-of-advanced-uveal-melanoma-on-tebentafusp https://www.immunocore.com/news-views-OLD/publicatiions/detail/22725/determining-t-cell-receptor-binding-orientation-and-peptide-hla-interactions-using-cross-linking-mass-spectrometry Sat, 01 Mar 25 00:00:00 -0500 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22725/determining-t-cell-receptor-binding-orientation-and-peptide-hla-interactions-using-cross-linking-mass-spectrometry https://www.immunocore.com/news-views-OLD/publicatiions/detail/22758/evolution-of-the-tumor-immune-landscape-during-treatment-with-tebentafusp-a-t-cell-receptor-cd3-bispecific Tue, 01 Apr 25 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22758/evolution-of-the-tumor-immune-landscape-during-treatment-with-tebentafusp-a-t-cell-receptor-cd3-bispecific https://www.immunocore.com/news-views-OLD/publicatiions/detail/22760/tandem-mass-spectrometry-fragmentation-patterns-of-sulfo-sda-cross-linked-peptides-european-journal-of-mass-spectrometry-2025-00 Thu, 01 May 25 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22760/tandem-mass-spectrometry-fragmentation-patterns-of-sulfo-sda-cross-linked-peptides-european-journal-of-mass-spectrometry-2025-00 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22762/online-aex-ms-analysis-of-biotherapeutic-charge-variants-using-a-bioaccord-lc-ms-system-waters-application-note-november-2023 Wed, 01 Nov 23 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22762/online-aex-ms-analysis-of-biotherapeutic-charge-variants-using-a-bioaccord-lc-ms-system-waters-application-note-november-2023 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22832/staeger-r-tastanova-a-ghosh-a-et-al-tebentafusp-elicits-on-target-cutaneous-immune-responses-driven-by-cytotoxic-t-cells-in-uveal-melanoma-patients-j-clin-invest-2025-13512-e181464-published-2025-apr-29-doi-10-1172jci181464 Tue, 01 Apr 25 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22832/staeger-r-tastanova-a-ghosh-a-et-al-tebentafusp-elicits-on-target-cutaneous-immune-responses-driven-by-cytotoxic-t-cells-in-uveal-melanoma-patients-j-clin-invest-2025-13512-e181464-published-2025-apr-29-doi-10-1172jci181464 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22834/szoke-kovacs-r-khakoo-s-rangel-vl-et-al-a-cd1c-lipid-agnostic-t-cell-receptor-bispecific-engager-redirects-t-cells-against-cd1c-cells-front-immunol-2025-16-1614610-published-2025-jul-24-doi-10-3389fimmu-2025-1614610 Tue, 01 Jul 25 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22834/szoke-kovacs-r-khakoo-s-rangel-vl-et-al-a-cd1c-lipid-agnostic-t-cell-receptor-bispecific-engager-redirects-t-cells-against-cd1c-cells-front-immunol-2025-16-1614610-published-2025-jul-24-doi-10-3389fimmu-2025-1614610 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22836/pope-hc-chiodetti-al-newey-a-et-al-cell-targeted-pd-1-agonists-are-potent-nk-cell-inhibitors-front-immunol-2025-16-1640509-published-2025-aug-22-doi-10-3389fimmu-2025-1640509 Fri, 01 Aug 25 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22836/pope-hc-chiodetti-al-newey-a-et-al-cell-targeted-pd-1-agonists-are-potent-nk-cell-inhibitors-front-immunol-2025-16-1640509-published-2025-aug-22-doi-10-3389fimmu-2025-1640509 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22838/powell-et-al-reliable-identification-of-intra--and-inter-molecular-cross-links-in-t-cell-receptor-complexes-2025-application-note-protein-metrics Wed, 01 Oct 25 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22838/powell-et-al-reliable-identification-of-intra--and-inter-molecular-cross-links-in-t-cell-receptor-complexes-2025-application-note-protein-metrics https://www.immunocore.com/news-views-OLD/publicatiions/detail/22840/sato-t-butler-mo-piperno-neumann-s-et-al-incidence-and-management-of-adverse-events-associated-with-tebentafusp-treatment-in-metastatic-uveal-melanoma-pooled-safety-analysis-of-410-patients-clin-cancer-res-published-online-september-12-2025-doi-10-11581078-0432-ccr-25-1513 Wed, 01 Oct 25 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22840/sato-t-butler-mo-piperno-neumann-s-et-al-incidence-and-management-of-adverse-events-associated-with-tebentafusp-treatment-in-metastatic-uveal-melanoma-pooled-safety-analysis-of-410-patients-clin-cancer-res-published-online-september-12-2025-doi-10-11581078-0432-ccr-25-1513 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22842/watkins-c-del-carpio-l-piulats-j-m-comment-on-tebentafusp-versus-nivolumab-plus-ipilimumab-for-metastatic-uveal-melanoma-an-evalue-sensitivity-analysis-assessing-effect-of-unmeasured-confounders-on-observational-associations-clin-drug-investig-2025-https-doi-org10-1007s40261-025-01468-1 Wed, 01 Oct 25 00:00:00 -0400 https://www.immunocore.com/news-views-OLD/publicatiions/detail/22842/watkins-c-del-carpio-l-piulats-j-m-comment-on-tebentafusp-versus-nivolumab-plus-ipilimumab-for-metastatic-uveal-melanoma-an-evalue-sensitivity-analysis-assessing-effect-of-unmeasured-confounders-on-observational-associations-clin-drug-investig-2025-https-doi-org10-1007s40261-025-01468-1